Genomic Subtypes of Non-invasive Bladder Cancer with Distinct Metabolic Profile and Female Gender Bias in KDM6A Mutation Frequency

Date: 
15 Nov 2017
Source: 
Journal Cancer Cell
Audience: 
Patients and public
Type of resource: 
Research

Bladder cancer incurs a higher lifetime treatment cost than other cancers due to frequent recurrence of non-invasive disease. Improved prognostic biomarkers and localized therapy are needed for this large patient group.

 

Click here to read the 'Research' article in full